Morusin, from the Root Bark of Morus alba, Ameliorates Bronchial Epithelial Cell Damage Induced by Cigarette Smoke

Guiren Feng,Jiaying Chen
DOI: https://doi.org/10.1007/s43450-022-00331-0
2022-11-04
Brazilian Journal of Pharmacognsosy
Abstract:Cigarette smoke is the most prevalent risk factor for chronic obstructive pulmonary disease. Morusin is prenylated flavonoid derived from the root bark of Morus alba L., Moraceae, and its potential benefits in chronic obstructive pulmonary disease are described in the present study. Human bronchial epithelial transformed cell line 16HBE was exposed to cigarette smoke to generate the experimental models. The impact of cigarette smoke extract and morusin on cell viability, inflammatory response, oxidative stress, and apoptosis was evaluated. According to the SuperPred database, Kruppel like factor 5 (KLF5) is considered to be the target of morusin. The association between morusin and KLF5 was discovered during the study of KLF5 overexpression on cells, companied by the determination of downstream signals of KLF5 pathway. Morusin attenuated the reduced cell viability and enhanced inflammatory response, oxidative stress, and apoptosis triggered by cigarette smoke extract. Morusin caused the decline of KLF5 level, and KLF5 overexpression reversed the protective impacts of morusin on cells. Morusin and KLF5 levels also influence the c-Jun N -terminal kinase (JNK)/p38 signaling, indicating that JNK/p38 signaling is one of the pathways regulated by morusin. This study demonstrates that morusin protects bronchial epithelial cells from cigarette smoke extract by downregulating KLF5 and blocking the JNK/p38 signaling pathway. The findings of this study provide a theoretical foundation for the therapeutic efficacy of morusin in chronic obstructive pulmonary disease.
What problem does this paper attempt to address?